Search - tctmd.com

Displaying 41 - 58 of 58

Sort: Relevancy | Date

Presentation TVT 2016

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

Presenter: Leo Marcoff, MD

June 16, 2016

Presentation TVT 2016

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

Expanding the Anatomical Limits for the MitraClip in FMR and DMR

Presenter: Samir R. Kapadia

June 16, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2016

Taped MitraClip Case - Complex MitraClip in DMR

Presenter: Francesco Maisano

June 16, 2016

Presentation TVT 2016

Patient/Anatomy Selection to Optimize MitraClip Success in FMR and DMR

Presenter: Paul A. Grayburn

June 16, 2016

Presentation TVT 2016

Overview of Mitral Anatomy for SH Therapy

Presenter: Francesco Maisano

June 16, 2016

Presentation TVT 2016

Outcomes of MitraClip in DMR: Synthesis of the Randomized Trials and Registries (US and EU)

Presenter: Anita Asgar

June 16, 2016

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation TVT 2014

Left Main Occlusion During Valve-in-Valve Treated by PC

Presenter: Danny Dvir

June 06, 2014

Presentation TVT 2013

The Case for the Hybrid OR-Cath Lab

Presenter: Michael Reardon

June 14, 2013

Presentation TVT 2013

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

Presenter: Mathew Williams

June 13, 2013

Presentation TVT 2013

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Presenter: Alain Cribier

June 13, 2013

Presentation TVT 2012

Complication of a Cerebral Protection Device

Presenter: 204222|Ronald Binder

June 02, 2012

Advertisement

TVT 1127: Persistent Transcathter Valve Thrombosis Despite Full Anticoagulation

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Expanding the Anatomical Limits for the MitraClip in FMR and DMR

The Case for and Against Cerebral Embolic Protection During TAVR

Taped MitraClip Case - Complex MitraClip in DMR

Patient/Anatomy Selection to Optimize MitraClip Success in FMR and DMR

Overview of Mitral Anatomy for SH Therapy

Outcomes of MitraClip in DMR: Synthesis of the Randomized Trials and Registries (US and EU)

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Left Main Occlusion During Valve-in-Valve Treated by PC

The Case for the Hybrid OR-Cath Lab

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Complication of a Cerebral Protection Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content